Aim: In thist retrospective study, we evaluated pain intensity, pharmalogical therapy, patient satisfaction and rising complications of 241 oncology patients that applied to Department of Algology outpatient clinic at Inonu University Medicine Faculty, between January 2011 and March 2012.
Material and Methods: Demographic data, opioid analgesics in pharmacological therapy, adjuvant therapy for neuropathic pain, additional disease, value of visual analogue scale baseline and visual analogue scale control, breakthrough pain, adverse effects and their treatment such as nausea and vomiting, constipation, pruritis, urine retention, sedation, and patient satisfaction were recorded.
Results: Weak opioids (61%), strong opioids (9.1%) and weak+strong opioids combinations (29.9%) had been preferred for pain therapy. It was detected that pregabalin (47.5%), amitriptilin (43.3%), gabapentine (7.5%) and gabapentine-amitiptilin combination (1.7%) were used in 84 (35%) patients for adjuvant therapy in neuropathic pain. As pain levels were modarate and severe (visual analogue scale baseline, 7.16±1.5) in the first application, control visual analogue scale values (visual analogue scale control 3.06±1.1) were 4 and lower than that in 90.5% of the patients. While the rate of satisfaction in therapy was 80%, incidence of nause and vomiting, constipation, sedation, urine retention, and pruritis were 30.3%, 19.5%, 19.1%, 10%, and 5%, respectively.
Conclusions: It was revealed that our data were compatible with data in literature about preference of opioid therapy, success rate and satisfaction of patients. We believed that patient satisfaction is high and incidence of adverse effects is low with well planned pain protocols in cancer pain management.
Key Words: Cancer Pain; Pain Management; Complication.
|